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Background:  Progressive  macular  hypomelanosis  (PMH)  is  a cosmetically  disturbing  skin
disorder  that is poorly  understood  with  indeﬁnite  treatment.  The  aim  of  the  present  study
was to clinically  outline  PMH  and  study  its  pathogenesis.  Based  upon  the  literature  suggest-
ing improvement  of  PMH  with  antibiotic  therapy  to  decrease  Propionibacterium  acnes  (P.
acnes)  colonization,  different  treatment  modalities  were  tried to  reach  the  best treatment
option.
Patients  and methods:  This  study  included  12  newly  diagnosed  PMH  selected  patients  who
attended  Tanta  University  Hospital  outpatient  clinic  of  Dermatology  and  Venereology  from
June 2009  to March  2010.  Patient’s  lesions  were  subjected  to  wood’s  lamp  and  potassium
hydroxide  (KOH)  examination  as well  as biopsies  used  in histological,  immunohistochemi-
cal,  bacteriological  and electron  microscopic  examination.  A randomized  clinical  trial  with
different treatment  modalities  was  applied.
Results: The  patient’s  mean  age  was  25  ±  10.8  with  signiﬁcant  female  predominance
(P  =  0.0001).  Reduction  of  epidermal  melanosomes  and  tyrosine  activity  together  with
difference  in  distribution  of  S100  proteins  in hypopigmented  skin  was  demonstrated.
Abnormal  distribution  of  tonoﬁlaments  was  noticed  inside  keratinocytes  with  increased
apoptosis.  P.  acnes  were  detected  in  hair  follicles  of  83.3%  hypopigmented  lesions.  Admin-
istration  of  local  and systemic  antimicrobial  treatment  with  narrow  band  ultraviolet  B
(NBUVB)  phototherapy  for 3 months  was  the  best  treatment  modalities.
Conclusion: The  etiology  of  PMH  is multifactorial  where  genetic  predisposition,  the  presence
of P. acnes  and hormonal  imbalance  play  the main  role.  Administration  of  local  and  systemic
antimicrobial  treatment  with  NBUVB  phototherapy  for 3  months  is  an  effective  treatment
regimen  for  PMH.
© 2014  Saudi  Society  of  Microscopes.  Published  by  Elsevier  Ltd.  All  rights  reserved.∗ Corresponding author. Tel.: +20 40 2241772; fax: +20 40 2239439;
obile: +20 1001052017.
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Progressive macular hypomelanosis (PMH), also known
as  idiopathic multiple large-macules or nummular and con-
ﬂuent  hypomelanosis of the trunk [1], is poorly understood
and often misdiagnosed cosmetically disturbing skin dis-
order  [2,3]. It occurs all over the world in young adults of
ghts reserved.
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all races and is characterized by symmetrically distributed
ill-deﬁned nummular, non-scaly, hypopigmented macules
mainly  on the trunk. Inﬂammatory predisposition is absent
and  the lesions tend to progressively increase in number,
sometimes extending to the neck, face, buttocks and upper
half  of extremities [4,5]. These lesions appear to be less
densely pigmented with less mature melanosomes than
normal  skin as indicated by histological and electron micro-
scopic  (EM) examination [6]. Up till now the course and
prognosis as well as speciﬁc treatment to PMH  is not well
known  [4].
Many  theories have been proposed to clarify its patho-
genesis, however, hard facts in support of these ideas are
lacking  [4]. Melting of genes between white and black par-
ents  in patients of mixed racial background was speculated
by  Guillet et al. [2]. Switching between type IV singly aggre-
gated  melanosomes to type I–III aggregated melanosomes
in the hypopigmented skin lesions of PMH  provided an evi-
dence  for such theory [7]. Because he noticed the disorder
only in family members, Borelli [8] suggested that PMH  is a
genodermatosis. According to Lesuer et al. [9], PMH  might
be  related to tinea versicolor although its causative organ-
ism,  the yeast Malassezia furfur, was never detected. In a
case  study report, Lo Schiavo et al. [10] pointed to the possi-
ble  role of antiretroviral drugs in the pathogenesis of PMH
as  they noticed that receiving post HIV prophylaxis was the
only  risk factor reported.
Westerhof  et al. [4] was the ﬁrst to offer Propionibac-
terium acnes (P. acnes) impact based on its presence in high
density  in their lesional skin pilosebaceous units and the
observed  red ﬂuorescence inside the hypopigmented spots
by  ultraviolet (UV) radiation. However, the mechanism by
which  P. acnes may  induce PMH  is uncertain, although sev-
eral  hypotheses were proposed. First, the production of
bacterial  enzymes with degradative properties that target
the  integrity of epidermal skin cells and the barrier func-
tion  of sebaceous follicles [11]. Second, P. acnes might be
involved  in triggering inﬂammation by constitutively pro-
duced  factors such as porphyrins, surface determinants like
a  glycocalyx polymer or stress proteins, an acid shift, or heat
shock  [11,12]. Last, P. acnes contain genes encode CAMP fac-
tor  homologs that act as pore-forming toxins [13,14], which
may  affect the function of melanocyte [4]. In contrary,
Relyveld et al. [15] hypothesize that the species causing
PMH differ from that causing acne, and cannot be differen-
tiated by conventional culture and biochemical methods.
The  aim of the present study was to clinically outline
PMH, study its histological and immunohistochemical pic-
tures  and determine its bacteriological aspect to throw
a  light on its pathogenesis. Based upon the literature
suggesting improvement of PMH  with antibiotic therapy
to  decrease P. acnes colonization [16], different treat-
ment modalities are tried to reach the best treatment
option.
2. Patients and methods2.1.  Patients
This study included 12 newly diagnosed PMH  selected
patients who attended Tanta University Hospitald Ultrastructure 2 (2014) 205–216
outpatient clinic of Dermatology and Venereology in
the  period from June 2009 to March 2010. The disease
was  discussed with the patients who  signed an informed
written consent.
2.1.1.  Inclusion criteria
The  chosen enrolled patients were selected according
to the following criteria: (a) clinically diagnosed cases
of  acquired, non scaly, conﬂuent, hypopigmented mac-
ules  and patches with normal sensation, (b) wood’s light
examination for accentuation of the clinically diagnosed
lesions and diagnosis of subclinically undiagnosed one, (c)
exclusion  of fungal infection by KOH examination, and (d)
histopathologically proven from biopsies taken from lesion
and  adjacent normal skin [2,7,16].
2.1.2. Exclusion criteria
Patients  were excluded if they had hypopigmentation
due to other diseases, they were under medical treatment
or  phototherapy for the disease or they refused skin biopsy.
2.1.3.  Controls
Control samples were taken from the apparently normal
nearby skin of the selected cases.
2.2. Methods
After complete history taking and thorough general and
cutaneous examination, patient’s lesions were subjected to
wood’s  lamp and KOH examination to conﬁrm the diag-
nosis  and exclude fungal infections. Skin of the selected
patients was disinfected and two punch biopsies (4 mm
each)  were taken from each patient, one from the hypo-
pigmented and the other from the normal nearby skin.
Specimens were divided into many parts for histological,
immunohistochemical, bacteriological and EM examina-
tion.
2.2.1. Wood’s lamp examination
Wood’s  lamp (Waldmann WTM) examination was done
according to Gilchrest et al. [17], with the following precau-
tions:  (a) patient’s skin was  examined from a distance of
5–20  in. after cleaning with alcohol in perfectly dark room,
and  (b) common sources of error as bluish or purplish ﬂu-
orescence produced by ointments on the skin-containing
petrolatum, green ﬂuorescence by salicylic acid contain-
ing  medicaments on the skin and light reﬂected from the
examiner’s white coat producing a light blue ﬂuorescence
were avoided.
2.2.2.  KOH examination
After  cleaning the skin with alcohol, scraping of the
hypopigmented skin on a clean sterile glass slide was  done,
followed by adding a drop of 15% KOH, then mixing. A cover
glass  was put over the preparation and was  allowed to
remain  at room temperature until the material has been
cleared which may  be warmed to speed the clearing pro-
cess.  Slides were examined by light microscope at X10, and
X40 power [18].
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.2.3. Histological examination
Specimens  were ﬁxed in 10% buffered formalin,
rocessed, and embedded in parafﬁn then subjected to:
.2.3.1.  Haematoxylin and eosin stain. Sections (5 mm
hick) were prepared for hematoxylin and eosin (H&E) from
issue  embedded parafﬁn blocks. Melanin pigment colored
rown  [19].
.2.3.2. Fontana-Masson silver stain. Sections were
eparafﬁnized in xylene, hydrated in a graded series of
lcohol  and treated with silver solution (ammonia in 20 ml
f  10% silver nitrates then 20 ml  of distilled water) at room
emperature over night in the dark. After washing, sec-
ions  were treated with 5% sodium thiosulphate for 2 min,
ashed,  dehydrated and mounted in Canada balsam.
elanin pigment appeared black [20].
.2.3.3. DOPA-oxidase reaction. This method was carried
ut  according to Praver and Tatcher [21]. Brieﬂy, sections
ere  placed in 0.1% DOPA in 0.1 phosphate buffer (pH 7.4)
t  37 ◦C for 1 h followed by immersion in another fresh
OPA reagent for 12 h at room temperature. After washing,
xation in Bouin’s solution was done for 24 h. Slides were
hen  dehydrated, cleared with xylene, and embedded in
ax.  Sections of 4 m thickness were put on glass slides,
ashed and H&E was used as a counter stain. On micro-
copic examination, brown granules of melanin appeared
t  the sites of DOPA-oxidase activity.
.2.4. Immunohistochemical staining
This staining was performed to detect the presence of
elanocytes in hypopigmented skin in comparison with
he  nearby normal looking skin. All reagents except the
rimary antibody were “universal kit”. Sections of 4 m
ere  cut from formalin ﬁxed parafﬁn embedded blocks
n  positive charged slides (Superfrost plus-Biogenix),
eparafﬁnized and rehydrated. Blocking of the endogenous
eroxidase was done by 3% hydrogen peroxide and antigen
etrieval was done by 10 ml  mol/L citrate buffer (pH 6.0).
locking reagent (normal mouse serum) was added fol-
owed  by S100 primary antibody (S-100 protein ab-1, clone
C4.9  ready to use for immunohistochemical stain) with an
ver  night incubation. The secondary biotinylated antibody
as  placed on each slide before exposure to streptavidin
nzyme label then color reagent and ﬁnally, Mayer’s hema-
oxylin  counterstain. Sections were dehydrated in alcohol
nd  mounted in DPX. Section of normal skin was  used as
ositive  control tissue for S100. Positive staining was indi-
ated  by the presence of brown color [22].
.2.5. Bacteriological examination
.2.5.1.  Bacterial culture. First, surface swabs were taken
rom  normal and hypopigmented skin and cultured accord-
ng  to the standard technique [23]. Then, parts of the biopsy
rom  normal-looking and hypopigmented skin were cul-
ured  after preparation by modiﬁcation of Westerhof et al.
4]  method. Biopsies were ground with few drops of broth
n  a sterile mill and tissues were immediately swabbed on
lood  agar plates. One half was cultured under aerobic con-
itions  (5% carbon dioxide at 37◦ C), and the other half wasd Ultrastructure 2 (2014) 205–216 207
cultured  under anaerobic conditions into an anaerobic jar
(80%  nitrogen/10% hydrogen/10% carbon dioxide) for 48 h
at  37◦ C. Colonies were identiﬁed by their morphology and
Gram  staining characters.
2.2.5.2.  Gram stain. Gram stain was  done for bacterial
smear from ground tissue and bacterial cultures as well as
from  unstained serial sections from the parafﬁn block [24].
2.2.6.  Electron microscopic examination
2.2.6.1. Electron microscope. Skin tissue specimen,
1–2 mm3 in size, was ﬁxed as soon as possible in 4%
paraformaldehyde for two  hours at 4 ◦C, washed by buffer
three  times for ten minutes each at 4 ◦C, post-ﬁxed in
1%  phosphate buffered osmium tetroxide for 30 min  and
washed  by buffer three times for 10 min  each at 4 ◦C.
Dehydration was  done in ascending grades of ethanol
at  4 ◦C. Specimens were transferred into pure propylene
oxide followed by propylene epoxy resin mixture then
pure  epoxy resin. Embedding was done in labeled capsule
ﬁlled  at about 2/3 of their volumes with fresh epoxy resin
mixture to which the accelerator dmp-30 was added as 1%
by  volume.
After polymerization in an oven for ﬁve days, sectioning
was performed where 0.5–1 m semi-thin sections were
used to select suitable areas for ultrathin sectioning for the
electron  microscopy. Ultrathin sections of either gray or
silver  color were picked upon 200 mesh naked copper grids.
The  grid with sections were dried then placed in a dust free
grid  box. Grids were stained by lead and uranium double
stained procedures, stored in grid box to be examined and
photographed [25].
2.2.6.2.  EM-DOPA reaction test. Small skin samples were
ﬁxed  with 2% glutaraldehyde and incubated in 0.1%
DOPA/phosphate buffer for 5 h at 37 ◦C, then post-ﬁxed in
1%  osmium tetroxide for 2 h. After dehydration, the speci-
mens  were embedded in Epon. Ultrathin sections were cut
and  examined by transmission electron microscopy [26].
2.3.  Therapeutic trials
In  this work, a randomized clinical trial of various ther-
apeutic modalities with different therapeutic lines were
performed using local erythromycin 2% lotion twice daily,
systemic doxycycline HCl 100 mg  twice daily, and narrow
band  ultraviolet B (NBUVB) with CosmedicoTM appara-
tus. In NBUVB clinical trial, the initial dose was  variable
according to the skin type and gradual until reaching the
minimal erythema dose. The sessions were done twice
weekly for periods ranging from 12 to 24 sessions with
or  without stimulation of melanogenesis. Of notice, two
patients refused to receive medical treatment to detect the
course  of the disease.
Several  modalities were tried: (1) Local and systemic
antibacterial treatment accompanied by NBUVB (2 patients
for  three months), (2) Local and systemic antimicrobial
treatment for one month followed by NBUVB for 2 months.
Patients were instructed to continue the local treatment
for two months with the same dose, but systemic treat-
ment  once daily for one month only (3 patients), (3) Local
208 A.M. Hassan et al. / Journal of Microscopy an
Table 1
Demographic and clinical characteristics of the studied patients.
Characters Value
Age, years (mean ± SD) 7–52 (25 ± 10.8)
Sex,  no (%)
Females 8 (67%)
Males  4 (33%)
Duration  of the lesion, months (median) 6–240 (94)
Size  of the lesion at diagnosis, cm (mean ± SD) 0.5–2 (1.1 ± 0.46)
Skin  type, no (%)
Skin  type III 2 (16.7%)
Skin  type IV 10 (83.3%)
Former  treatment, no (%)
Antifungal drugs 8 (66.7%)
Topical  corticosteroids 1 (8.3%)
aNBUVB 1 (8.3%)
No  treatment 2 (16.7%)
a NBUVB: narrow band UVB.
and systemic treatment without NBUVB (2 patients), (4)
Local  treatment accompanied by NBUVB for three months
(one  patient), (5) Local treatment only for three months
(one patient), and (6) NBUVB only for three months (one
patient).
Randomization was done by closed envelope method.
Assessment of the results were obtained according to three
dermatologic points of view who were blinded for the
assigned treatment modality plus the patient opinion and
scoring  photographs before and after treatment during the
three  months of treatment and over a follow up period of
about  six months. Scoring of the results was fair: < 25%,
good:  25-50%, very good: > 50–75% and excellent: >75%
according to the number of repigmented lesions.
2.4. Statistical analysis
It  was performed by using SPSS for Windows, version 9.
Data  were expressed as range and mean ± standard devi-
ation  (SD)/median or numbers and percentages. Pearson
Correlation Coefﬁcient was used to detect the relation
between variants. Univariate analysis was done by Fisher’s
exact  test. For all statistical tests done, P value < 0.05 was
considered signiﬁcant.
3.  Results
This study included 12 patients with PMH  selected from
outpatient clinic of Tanta University Hospitals. Their ages
ranged  from 7 to 52 years (mean ± SD: 25 ± 10.8). There
was  female predominance (67% females vs. 33% males,
P  = 0.0001). Two patients were skin type III and 10 patients
were  skin type IV according to Fitzpatrick classiﬁcation of
skin  type [27] (Table 1).
3.1.  Clinical results
The  duration of the lesions in the studied cases ranged
from 6 months to 20 years. Pearson Correlation Coefﬁ-
cient has revealed that both age and the duration of the
disease were negatively correlated with the size of mac-
ules  (−0.31 and −0.41, respectively) (Fig. 1). All patients
were Egyptian patients of unmixed ethnicities who  had nod Ultrastructure 2 (2014) 205–216
history  of recreational sun exposure. Regarding previous
treatment, 8 patients used previous topical and systemic
antifungal drugs with no effect, one patient was diagnosed
as  post eruptive hypopigmentation, and another one had
many  previous diagnoses such as vitiligo, post eruptive
hypopigmentation and pityriasis alba. Only two  patients
were  asking medical advice for the ﬁrst time. Interest-
ingly, two  of the patients were twins while the rest of the
patients gave no family history. (Table 1) No history of
consanguinity was obtained in all patients. In one patient
lesions extended on the buttock while in another patient
lesions were also present on the breast and neck and 50%
of  patients had acne lesions on the face.
3.2. Histological results
Histological  examination with H&E stain had excluded
all other diseases that could be differentiated from PMH.
It  also revealed decreased melanization in the epidermis
compared with the adjacent healthy skin with no abnor-
malities in the dermis. In the lesional skin of 7 (58.3%)
patients, there was  a mild perifolliculitis with bacteria
residing inside the hair follicle. In the stratum corneum,
no spores, hyphae, or bacteria were seen (Photo 1). By
Fontana-Masson stain, the melanin content was  evalu-
ated. All hypopigmented lesions showed decrease melanin
granules concentration as compared with normal skin
(20%–30% vs. 50%–72%, P = 0.012). (Photo 2; Fig. 2) Dopa-
oxidase reaction was performed to evaluate the activity of
tyrosinase  enzyme. A decreased in this reaction was  notice
in  hypopigmented skin than normal skin (Photo 3).
3.3.  Immunohistochemical results
There was  apparently no difference in the number of S-
100  protein-positive cells between the hypopigmented and
normal-appearing skin. However, on high power magniﬁ-
cation there was  difference in distribution of these proteins
where  in normal skin it was  mainly supranuclear, but in
hypopigmented skin it is dispersed all over the cell (Photos
4  and 5).
3.4.  Bacteriological results
3.4.1.  Gram stain
Grams  positive, non-sporing bacilli of P. acnes were seen
in  hypopigmented skin (7 patients, 58.3%, P = 0.0046) and
absent  in normal skin. They were detected in both serial
sections from unstained parafﬁn block (Photo 6a) and in
bacterial  smear from ground skin biopsy (Photo 6b) and
from  bacterial culture.
3.4.2.  Bacterial culture
Anaerobic  cultures were positive for P. acnes in hypopig-
mented skin and negative in normal skin. The bacilli were
detected by modiﬁcation of Westerhof et al. method [1]
not  in surface swabs. Bacterial growth was identiﬁed by
morphologic colony type, which showed arborizing growth
pattern  and the violet rod-like structure of the gram stain-
ing.
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.5. Electron microscope results
.5.1. Ultrastructural results
Lesional  skin contains signiﬁcantly more immature
elanosomes (Photo 7a), while normal skin contain more
ature  melanosomes (Photo 7b) with a P value less than
.0001.  Normal skin type III showed signiﬁcant predom-
nance of stage three mature melanosomes, while normal
kin  type IV showed signiﬁcant predominance of stage four
ature  melanosomes (P < 0.0001). (Fig. 3) In normal skin
elanosomes are mainly supranuclear (Photos 7b and 8a),
hoto 1. H&E light micrograph of (a) normal, (b) diseased skin showing decrease
00×.  (c) Hair follicle containing microorganism in hypo-pigmentation area and
00×.  Hypo-pigmentation lies above level of hair follicle (green arrow) (d) hair foe (A) and duration (B) of the disease and size of the macules. Pearson
while  in the hypopigmented skin melanosomes are dis-
persed  all around the nucleus and are surrounded by a
band  of tonoﬁlaments, which form a mesh entrapping them
(Photo  7a). Increased keratinocyte apoptosis in hypopig-
mented (Photos 8b and c) than in normal-looking skin
(Photo 8d).3.6.  Response to different therapeutic modalities
Two patients had refused treatment and excluded
from this clinical trial. Treatment with local and systemic
d melanin content (brown) in diseased skin compared with normal skin,
 surrounded by mild peri-lesional inﬂammatory inﬁltrate (black arrow),
llicle containing microorganism, 1000×.
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Photo 2. Fontana-Masson light micrograph of PMH  diseased skin “b” and nearby normal skin “a” type IV showing marked condensation of melanin granules
in  normal skin and poor concentration in PMH  patients. Magniﬁcation power 1000× with oil.
es conceFig. 2. Percentages of melanin granul
antimicrobial agent in addition to NBUVB gave the best
outcome with complete cure in both cases after 3 months
of  therapy and without any signs of relapse during the
follow  up period (Photo 9). Nearly similar proﬁle but with
slightly  lower sensitivity was notice in the patient who
Photo 3. Decreased dopa-oxidase reaction (brown color) ntration in normal and lesional skin.
received local antimicrobial therapy with NBUVB (92%) for
3  months, that who  exposed to NBUVB (90%) only for 3
months  and those who had local and systemic antimi-
crobial agents for one month followed by NBUVB (90%).
However, treatment with local and systemic antimicrobial
in hypopigmented (b) than normal (a) skin, 400×.
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Photo 4. S-100 protein-positive cells showing apparently no difference between normal (a) and hypopigmented (b) skin, 400×.
Photo 5. S-100 protein-positive cells showing difference in distribution of S-100 protein inside normal (a) and hypopigmented (b) cells (red arrows),
1000×.
Photo 6. Gram-positive bacilli inside hair follicle (a) and in bacterial smear from skin biopsy (b).
Table 2
Outcome of active treatment using different modalities (3 months) and at the end of follow-up period (6 months).
Outcome Treatment modalitiesc
1 (2 patients) 2 (3 patients) 3 (2patients) 4 (1 patient) 5 (1 patient) 6 (1 patient)
One montha 60% 35% 30% 45% 27% 24%
Two  monthsa 82% 65% 46% 70% 50% 72%
Three monthsa 100% 90% 73% 92% 74% 90%
Relapse after cessation
of  therapyb
No No No No No After one month
a Average % of re-pigmented lesions.
b Relapsed lesions within or at the end of 6 months follow up period.
c Different treatment modalities: (1) Local and systemic antibacterial treatment accompanied by NBUVB, (2) Local and systemic antimicrobial treatment
for  one month followed by NBUVB for 2 months, (3) Local and systemic treatment without NBUVB, (4) Local treatment accompanied by NBUVB for three
months,  (5) Local treatment only for three months, and (6) NBUVB only for three months.
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Photo 7. Electron micrograph of (a) hypopigmented skin type III showing immature melanosomes mainly stage one (black arrows) and two  (red arrows).
Notice  abnormal distribution of tonoﬁlaments (blue arrows), (b) normal skin type III showing mature melanosomes mainly stage III (arrows). Note: normal
distribution  of tonoﬁlaments, 1500×.
ional skFig. 3. Comparison of melanosome maturation between normal and les
compared  to normal skin (P < 0.0001).
agents for one month followed by NBUVB gave complete
cure in about 5 months in one case, while use of NBUVB was
the  only modality that showed relapse after one month. Of
notice,  the lowest response was detected in the 3rd and 5th
modalities  where NBUVB was not applied (73% and 74%)
(Table  2).
4.  Discussion
Progressive macular hypomelanosis is a poorly under-
stood skin disorder characterized by hypopigmented
macules without scales, history of skin problems or effec-
tive  treatment [5]. To the best of our knowledge, until the
present  date PMH  has not been fully reported in Africa
or  Middle East. The present study aimed to describe PMH
on  the basis of clinical, histological, immunohistochemical,in. Immature melanosomes were signiﬁcantly detected in lesional skin
microbiological, and ultrastructural study in a trial to gain
an  insight into its pathogenesis and therefore the best treat-
ment  modality.
In  the present work the mean age of onset was 25 years
with signiﬁcant female predominance. Several authors
have observed PMH  only in adolescents and young adults
[2,4,27,28]. However our observation of PMH  in a young
child  may  open a wide range for PMH  incidence. On the
other  hand, the female predominance may  be related to the
fact  that women  are known to seek medical advice more for
cosmetic  reasons, especially at the age of marriage, hor-
monal  imbalance, and/or the random choice of patients.
Neynaber et al. [5] noticed progression of hypopigmen-
tation during pregnancy. Guillet et al. [7] and Westerhof
et al. [4] observed PMH  mainly in women, but Borelli
[8], mentioned an equal distribution in both sexes. Other
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elanosomes  (green arrows). Note: increased keratinocyte apoptosis (blu
tudies pointed to male predominance in PMH  [29–31].
wang et al. [28] concluded that the exact prevalence of
MH  is unknown. It is worth to be noted that several
atients were diagnosed clinically with typical PMH  symp-
oms,  but were excluded from their study because of their
hoto 9. PMH  after3 months of combined and local and systemic antibacterial t
reatment. mature melanosomes stage four (red arrows) and little apoptosis (blue
uclear mainly (b) and (c) hypopigmented skin showing mainly immature
s) and abnormal distribution of tonoﬁlaments (red arrows), 1000×.
refusal  of skin biopsy, which support the under-reporting
of PMH  cases. Acne vulgaris on the face was detected in
half  of patients, however, consistent with other studies
[4,15], acne does not seem to predispose for PMH  in this
study.
reatment and NBUVB (ﬁrst modality): (a) before treatment and (b) after
scopy an214 A.M. Hassan et al. / Journal of Micro
Clinically, the majority of patients were skin type IV
that  may  be due to the fact that white spots are more
easily recognized on pigmented skin [4]. Regarding the
course  of the disease, spontaneous regression of PMH
was  not detected from history or over the follow up
period in spit of the negative correlation detected between
both  age and duration of the disease with the size of
the  macules. However, the term progressive is misnomer
because after hypopigmentation reaches certain limit in
every  patient, it becomes stationary. There are many
follow-up reports of PMH. Guillet et al. [2] suggested
that hypopigmented lesions spontaneously decrease after
2–5  years. Hwang et al. [28] followed 3 patients who
did not receive treatment for 3 months. Only one of
those patients improved, with a time-to-repigmentation
of 8 years. They concluded that more extensive follow-
up  is needed to conﬁrm the spontaneous resolution of
PMH.  Symmetrical distribution of the macules is docu-
mented [2,3,5,6]. Recently, Wen  et al. [32] reported their
ﬁrst  PMH  case with asymmetrically distributed lesions,
which suggesting the existence of some other subtypes of
PMH.
Although  this study showed the presence of mature
melanocytes in hypopigmented lesions with no appar-
ent  difference in the number of S-100 protein-positive
cells between the hypopigmented and normal skin, reduc-
tion  of epidermal melanization of melanosomes, melanin
granules concentration together with difference in distri-
bution  of S100 proteins in hypopigmented than normal
skin, which was more manifest in Fitzpatrick skin type
IV  than type III, was demonstrated. Additionally, abnor-
mal  distribution of tonoﬁlaments was also noticed inside
keratinocytes with presence of disintegrated melanosomes
in  the lysosomal compartments and increased apopto-
sis.  These observations pointed to that the disease is
not  caused by abnormalities in melanocytes and PMH  is
hypomelanotic not hypomelanocytic, which may be due
to  the abnormal distribution of tonoﬁlaments resulting in
changing  of the maturation, size, number and distribu-
tion of melanosomes in lesional skin [33]. On the contrary,
Relyveld et al. [27] found no defects in melanosome degra-
dation  and they concluded that a decrease in melanin
synthesis must be the explanation for hypopigmentation in
PMH.
In  a trial to go in depth of the pathogenesis of hypome-
lanosis noticed and proved by EM suggesting that there is
probably  a functional defect in pigmentation or a problem
in  melanin distribution, further ultrastructural examina-
tion was done using EM-DOPA technique to demonstrate
the status of tyrosinase activity for the ﬁrst time in
PMH. After incubation with DOPA solution nearly all
melanosomes changed to stage four mature melanosomes
in normal skin, while only some immature melanosomes
changed to mature stage three and four melanosomes
in hypopigmented skin with detection of stages one and
two  melanosomes and indicating a reduced tyrosinase
activity.In this study, bacterial examination was done to detect
P.  acnes, which were incriminated by Westerhof et al. [4]
to  be the causative factor of PMH. They added that the
mechanism they propose is not new in the biology ofd Ultrastructure 2 (2014) 205–216
pigmentary disorder. In 1986, Nazzaro-Porro et al. [34] sug-
gested  that the hypopigmentation in PV is probably due to
toxic  lipoperoxidases formed by the action of Pityrospo-
rum ovale on the unsaturated lipids of the skin surface.
However, the mechanism by which P. acnes trigger PMH  is
not  certain, but stress, production of degradative enzymes,
provoking of inﬂammation or production of pore-forming
toxin are attractive theories [11–14].
Gram-positive bacteria were found in the serial sections
of  the pilosebaceous ducts of hypopigmented skin and were
absent  in normal skin, and P. acnes have been cultured from
follicular  lesional skin from patients with PMH. It is worth
to  be noted that surface swabs cannot detect P. acnes as it
lies  deep in the hair follicle [4]. Red follicular ﬂuorescence
was  not observed in this study which may  be due to that
a  density of 1000 P. acne organisms were required for fol-
licular  ﬂuorescence to occur as was explained by McGinley
et  al. [35].
We  have tried different therapeutic modalities in a clini-
cal  trial to test a treatment regimen that is directed against
the  P. acnes with or without stimulation of melanogene-
sis. It was noticed that NBUVB combined with topical and
systemic antimicrobial gave the most excellent response
with complete cure. On the other hand, the use of antimi-
crobial agents alone and relapse after one month stoppage
of  NBUVB alone suggests that P. acnes have a role in the
pathogenesis of the disease while NBUVB has a role in accel-
eration  of cure.
Several  studies have tried several therapeutic modal-
ities to treat PMH  as topical and systemic antifungal
agents, topical steroids, topical antimicrobial agents, and
phototherapy, however, no consistently effective therapy
has  been established [16,28,36–38]. Relyveld et al. [16]
compared the effectiveness of antimicrobial lotions with
anti-inﬂammatory cream in patients with PMH. They con-
cluded  that antimicrobial therapy with UVA was  a more
effective treatment modality, which supports the hypoth-
esis  of Westerhof et al. [4] that PMH  is causally related
to P. acnes. Similar result was obtained by Wu et al. [39]
and  supported by Cavalcanti et al. [40] who treated a
series  of thirteen PMH  patients with an association of anti-
acne  lymecycline and benzoyl peroxide over a three-month
period. Response to treatment was  excellent and the pos-
itive  results were maintained during the entire follow up
period.  Later on, Kim et al. [41] showed similar excellent
response to oral isotretinoin which is used for treatment of
sever  acne.
Regarding phototherapy, Choi and Hann [42] have
observed disappearance of the hypopigmented spots with
psoralen  plus UVA (PUVA) therapy but after cessation
of this treatment, the induced pigmentation disappeared
immediately and resulted in a pattern of hypopigmentation
exactly as before. This phenomenon is possibly the result
of  temporary inhibition of P. acnes by PUVA therapy while
stimulating melanogenesis. Of notice, Chung et al. [36]
reported that his patient improved after NBUVB photother-
apy.  Hwang et al. [28] noticed that six patients treated with
NBUVB  phototherapy showed marked repigmentation and
hypopigmented lesions did not recur during 3–13 months
of  follow-up suggesting that NBUVB phototherapy is an
effective  treatment. Such results were supported by Kim
scopy an
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ment  of progressive macular hypomelanosis: a prospective study. AnA.M. Hassan et al. / Journal of Micro
t al. [43]. NBUVB phototherapy was shown to promote
elanocyte proliferation and migration and to diminish
he  activation of interleukin-6 and tumor necrosis factor-
,  which suppress melanin synthesis [44]. On the contrary,
n  the comparative study of Duarte et al. [45] no signiﬁ-
ant difference was found between the outcomes obtained
ith  PUVA and those obtained with narrowband UVB pho-
otherapy  and they concluded that they did not prevent
ecurrence of the disease.
In  conclusion, the present study suggested that the eti-
logy  of PMH  is multifactorial where genetic predisposition
ay  play a role for the reason that two of our patients
ere twins and the occurrence of PMH  in a young child,
ogether with the presence of P. acnes which may  suppress
he  tyrosinase enzyme and affect melanosome transfer
nside keratinocytes and hormonal imbalance as most of
atients  included in this study were young females had
he  main role. Additionally, administration of local and sys-
emic  antimicrobial treatment with NBUVB phototherapy
or 3 months was the best treatment modality in PMH.
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